Antithrombotic treatment and outcome after endovascular treatment and acute carotid artery stenting in stroke patients with atrial fibrillation

BACKGROUND: Oral anticoagulation (OAC) is the mainstay of secondary prevention in ischemic stroke patients with atrial fibrillation (AF). However, in AF patients with large vessel occlusion stroke treated by endovascular therapy (ET) and acute carotid artery stenting (CAS), the optimal antithromboti...

Descripción completa

Detalles Bibliográficos
Autores principales: Weller, Johannes M., Dorn, Franziska, Meissner, Julius N., Stösser, Sebastian, Beckonert, Niklas M., Nordsiek, Julia, Kindler, Christine, Riegler, Christoph, Keil, Fee, Petzold, Gabor C., Bode, Felix J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465921/
https://www.ncbi.nlm.nih.gov/pubmed/36089621
http://dx.doi.org/10.1186/s42466-022-00207-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465921/
https://www.ncbi.nlm.nih.gov/pubmed/36089621
http://dx.doi.org/10.1186/s42466-022-00207-7

Ejemplares similares